[Significance of the Mizushima test (Mt) for the evaluation of antirheumatics].
D000818:Animals; D000893:Anti-Inflammatory Agents; D001391:Azo Compounds; D001798:Blood Proteins; D011232:Chemical Precipitation; D004285:Dogs; D004336:Drug Antagonism; D005439:Flufenamic Acid; D006168:Guinea Pigs; D000882:Haplorhini; D006358:Hot Temperature; D006801:Humans; D066298:In Vitro Techniques; D007213:Indomethacin; D008251:Macaca; D008722:Methods; D010653:Phenylbutazone; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013810:Therapeutic Equivalency
D000893:Anti-Inflammatory Agents; D001391:Azo Compounds; D001798:Blood Proteins; D005439:Flufenamic Acid; D010653:Phenylbutazone; D007213:Indomethacin
Zur Bedeutung des Mizushima-Tests (mt) für die Beurteilung der Antirheumatika.